{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:34:37Z","timestamp":1791531277445,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009401","name":"LMU | Medizinischen Fakult\u00e4t, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>SMARCB1-deficient sinonasal carcinoma (SDSC) is a rare, highly aggressive malignancy with limited therapeutic options and no established preclinical models. Here, single-nucleus RNA sequencing (snRNAseq), spatial transcriptomics, and ex vivo patient-derived tissue slice culture (TSC) were combined to resolve intratumoral heterogeneity, niche organization, and treatment vulnerabilities in an index SDSC. snRNAseq identified three malignant subpopulations, including two specialized states marked by ALDH1A1 and NTN4. Spatial profiling mapped these states to distinct niches. The ALDH1A1+ compartment localized to a basal-associated niche with intermingled p63-positive basal cells adjacent to stroma, showed reduced proliferative activity, and displayed stem-like transcriptional features. Ex vivo drug testing revealed a striking response: the mTOR inhibitor Sapanisertib induced extensive tumor necrosis and was associated with near-complete depletion of ALDH1A1+ and NTN4+ states, accompanied by strong stress\/apoptosis signatures and reduced endothelial cells. In an additional retrospective cohort of 12 SDSC, ALDH1A1 was present in all cases with heterogeneous spatial patterns and higher levels in recurrences. Mesothelin was expressed in the index case and a subset of tumors, supporting mesothelin-directed therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s44321-026-00437-1","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T18:26:35Z","timestamp":1777746395000},"page":"2360-2378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spatially resolved ex vivo drug response profiling in SMARCB1-deficient sinonasal carcinoma"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7745-3794","authenticated-orcid":false,"given":"Philipp","family":"Jurmeister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Flach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Bergmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstanze","family":"Schleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4559-0726","authenticated-orcid":false,"given":"Edgar","family":"Chimal Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6960-748X","authenticated-orcid":false,"given":"Liliana","family":"H Mochmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yauheniya","family":"Zhdanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Klingler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Pusztai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3368-6497","authenticated-orcid":false,"given":"Anna","family":"K\u00fcbler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6284-6153","authenticated-orcid":false,"given":"Christoph","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph Benedikt","family":"Westphalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Leitheiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-3667","authenticated-orcid":false,"given":"Gerben E","family":"Breimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A","family":"Rijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lot","family":"Devriese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2759-4737","authenticated-orcid":false,"given":"Philipp","family":"Baumeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Sk\u00e1lov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Schallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Klauschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-9166","authenticated-orcid":false,"given":"Andreas","family":"Mock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"437_CR1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/PAS.0000000000000797","volume":"41","author":"A Agaimy","year":"2017","unstructured":"Agaimy A, Hartmann A, Antonescu CR, Chiosea SI, El-Mofty SK, Geddert H, Iro H, Lewis JS, M\u00e4rkl B, Mills SE et al (2017) SMARCB1 (INI-1)-deficient sinonasal carcinoma. Am J Surg Pathol 41:458\u2013471","journal-title":"Am J Surg Pathol"},{"key":"437_CR2","doi-asserted-by":"crossref","first-page":"btag055","DOI":"10.1093\/bioinformatics\/btag055","volume":"42","author":"M Andreatta","year":"2026","unstructured":"Andreatta M, Carmona SJ (2026) UCell and pyUCell: single-cell gene signature scoring for R and Python. Bioinformatics 42:btag055","journal-title":"Bioinformatics"},{"key":"437_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tcb.2012.02.006","volume":"22","author":"C Appenzeller-Herzog","year":"2012","unstructured":"Appenzeller-Herzog C, Hall MN (2012) Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol 22:274\u2013282","journal-title":"Trends Cell Biol"},{"key":"437_CR4","doi-asserted-by":"crossref","first-page":"vbac016","DOI":"10.1093\/bioadv\/vbac016","volume":"2","author":"P Badia-i-Mompel","year":"2022","unstructured":"Badia-i-Mompel P, Santiago JV, Braunger J, Geiss C, Dimitrov D, M\u00fcller-Dott S, Taus P, Dugourd A, Holland CH, Flores ROR et al (2022) decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinform Adv 2:vbac016","journal-title":"Bioinform Adv"},{"key":"437_CR5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG et al (2017) QuPath: Open source software for digital pathology image analysis. Sci Rep 7:16878","journal-title":"Sci Rep"},{"key":"437_CR6","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-10-106","volume":"10","author":"U Bharadwaj","year":"2011","unstructured":"Bharadwaj U, Marin-Muller C, Li M, Chen C, Yao Q (2011) Mesothelin confers pancreatic cancer cell resistance to TNF-\u03b1-induced apoptosis through Akt\/PI3K\/NF-\u03baB activation and IL-6\/Mcl-1 overexpression. Mol Cancer 10:106","journal-title":"Mol Cancer"},{"key":"437_CR7","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000000285","volume":"38","author":"JA Bishop","year":"2014","unstructured":"Bishop JA, Antonescu CR, Westra WH (2014) SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract. Am J Surg Pathol 38:1282\u20131289","journal-title":"Am J Surg Pathol"},{"key":"437_CR8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable DM, Murray E, Zou LS, Goeva A, Macosko EZ, Chen F, Irizarry RA (2022) Robust decomposition of cell type mixtures in spatial transcriptomics. Nat Biotechnol 40:517\u2013526","journal-title":"Nat Biotechnol"},{"key":"437_CR9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/jnci\/djad085","volume":"115","author":"SN Chi","year":"2023","unstructured":"Chi SN, Yi JS, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA et al (2023) Tazemetostat for tumors harboring SMARCB1\/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C. J Natl Cancer Inst 115:1355\u20131363","journal-title":"J Natl Cancer Inst"},{"key":"437_CR10","doi-asserted-by":"crossref","first-page":"e39679","DOI":"10.1371\/journal.pone.0039679","volume":"7","author":"S-D Chou","year":"2012","unstructured":"Chou S-D, Prince T, Gong J, Calderwood SK (2012) mTOR Is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesis. PLoS ONE 7:e39679","journal-title":"PLoS ONE"},{"key":"437_CR11","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.3390\/cancers14153645","volume":"14","author":"GW Cooper","year":"2022","unstructured":"Cooper GW, Hong AL (2022) SMARCB1-deficient cancers: novel molecular insights and therapeutic vulnerabilities. Cancers 14:3645","journal-title":"Cancers"},{"key":"437_CR12","doi-asserted-by":"crossref","first-page":"btae029","DOI":"10.1093\/bioinformatics\/btae029","volume":"40","author":"B Daenekas","year":"2024","unstructured":"Daenekas B, P\u00e9rez E, Boniolo F, Stefan S, Benfatto S, Sill M, Sturm D, Jones DTW, Capper D, Zapatka M et al (2024) Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice. Bioinformatics 40:btae029","journal-title":"Bioinformatics"},{"key":"437_CR13","doi-asserted-by":"crossref","first-page":"e28386","DOI":"10.1371\/journal.pone.0028386","volume":"6","author":"D Dangaj","year":"2011","unstructured":"Dangaj D, Abbott KL, Mookerjee A, Zhao A, Kirby PS, Sandaltzopoulos R, Powell DJ, Lamazi\u00e8re A, Siegel DL, Wolf C et al (2011) Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody. PLoS ONE 6:e28386","journal-title":"PLoS ONE"},{"key":"437_CR14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s40136-023-00495-w","volume":"11","author":"S Danti","year":"2023","unstructured":"Danti S, Ricci C, Macchi T, Dallan I, Berrettini S, Franchi A (2023) SWI\/SNF-deficient sinonasal carcinomas: multidisciplinary research perspectives. Curr Otorhinolaryngol Rep 11:472\u2013481","journal-title":"Curr Otorhinolaryngol Rep"},{"key":"437_CR15","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2318-x","volume":"16","author":"J Donnadieu","year":"2016","unstructured":"Donnadieu J, Lachaier E, Peria M, Saidak Z, Dakpe S, Ikoli J-F, Chauffert B, Page C, Galmiche A (2016) Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies. BMC Cancer 16:273","journal-title":"BMC Cancer"},{"key":"437_CR16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/bjc.2013.700","volume":"110","author":"MM Gerlach","year":"2014","unstructured":"Gerlach MM, Merz F, Wichmann G, Kubick C, Wittekind C, Lordick F, Dietz A, Bechmann I (2014) Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance. Br J Cancer 110:479\u2013488","journal-title":"Br J Cancer"},{"key":"437_CR17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S et al (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555\u2013567","journal-title":"Cell Stem Cell"},{"key":"437_CR18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S1470-2045(20)30451-4","volume":"21","author":"M Gounder","year":"2020","unstructured":"Gounder M, Sch\u00f6ffski P, Jones RL, Agulnik M, Cote GM, Villalobos VM, Attia S, Chugh R, Chen TW-W, Jahan T et al (2020) Tazemetostat in advanced epithelioid sarcoma with loss of INI1\/SMARCB1: an international, open-label, phase 2 basket study. Lancet Oncol 21:1423\u20131432","journal-title":"Lancet Oncol"},{"key":"437_CR19","doi-asserted-by":"crossref","first-page":"1145817","DOI":"10.3389\/fonc.2023.1145817","volume":"13","author":"MDC Greier","year":"2023","unstructured":"Greier MDC, Runge A, Dudas J, Carpentari L, Schartinger VH, Randhawa A, Mayr M, Petersson M, Riechelmann H (2023) Optimizing culturing conditions in patient derived 3D primary slice cultures of head and neck cancer. Front Oncol 13:1145817","journal-title":"Front Oncol"},{"key":"437_CR20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","volume":"8","author":"M Guba","year":"2002","unstructured":"Guba M, Breitenbuch P, von, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M et al (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8:128\u2013135","journal-title":"Nat Med"},{"key":"437_CR21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ygyno.2023.09.013","volume":"178","author":"SN Han","year":"2023","unstructured":"Han SN, Oza A, Colombo N, Oaknin A, Raspagliesi F, Wenham RM, Braicu EI, Jewell A, Makker V, Krell J et al (2023) A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer. Gynecol Oncol 178:110\u2013118","journal-title":"Gynecol Oncol"},{"key":"437_CR22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, Srivastava A, Molla G, Madad S, Fernandez-Granda C et al (2024) Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol 42:293\u2013304","journal-title":"Nat Biotechnol"},{"key":"437_CR23","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.19.02085","volume":"38","author":"R Hassan","year":"2020","unstructured":"Hassan R, Blumenschein GR, Moore KN, Santin AD, Kindler HL, Nemunaitis JJ, Seward SM, Thomas A, Kim SK, Rajagopalan P et al (2020) First-in-human, multicenter, phase I dose-escalation and expansion study of anti-mesothelin antibody\u2013drug conjugate anetumab ravtansine in advanced or metastatic solid tumors. J Clin Oncol 38:1824\u20131835","journal-title":"J Clin Oncol"},{"key":"437_CR24","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1200\/JCO.2016.68.3672","volume":"34","author":"R Hassan","year":"2016","unstructured":"Hassan R, Thomas A, Alewine C, Le DT, Jaffee EM, Pastan I (2016) Mesothelin immunotherapy for cancer: ready for prime time? J Clin Oncol 34:4171\u20134179","journal-title":"J Clin Oncol"},{"key":"437_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34815-3","volume":"13","author":"P Jurmeister","year":"2022","unstructured":"Jurmeister P, Gl\u00f6\u00df S, Roller R, Leitheiser M, Schmid S, Mochmann LH, Capilla EP, Fritz R, Dittmayer C, Friedrich C et al (2022) DNA methylation-based classification of sinonasal tumors. Nat Commun 13:7148","journal-title":"Nat Commun"},{"key":"437_CR26","doi-asserted-by":"crossref","unstructured":"Korsunsky I, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh P-R, Raychaudhuri S (2019) Fast, sensitive, and accurate integration of single cell data with Harmony. Nat Methods 16:1289\u20131296","DOI":"10.1038\/s41592-019-0619-0"},{"key":"437_CR27","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1038\/s41388-023-02859-4","volume":"42","author":"Y Li","year":"2023","unstructured":"Li Y, Giovannini S, Wang T, Fang J, Li P, Shao C, Wang Y, centre T, Agostini M, Bove P et al (2023) p63: a crucial player in epithelial stemness regulation. Oncogene 42:3371\u20133384","journal-title":"Oncogene"},{"key":"437_CR28","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.immuni.2025.08.009","volume":"58","author":"G Liao","year":"2025","unstructured":"Liao G, Nakayama T, Zhu B, Lee IT, Yeung J, Yeo YY, Chang Y, Wang C, Liao SC-K, Nkosi D et al (2025) Multi-scaled transcriptomics of chronically inflamed nasal epithelium reveals immune-epithelial dynamics and tissue remodeling in nasal polyp formation. Immunity 58:2593\u20132608.e6","journal-title":"Immunity"},{"key":"437_CR29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrclinonc.2014.97","volume":"11","author":"JL Llorente","year":"2014","unstructured":"Llorente JL, L\u00f3pez F, Su\u00e1rez C, Hermsen MA (2014) Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances. Nat Rev Clin Oncol 11:460\u2013472","journal-title":"Nat Rev Clin Oncol"},{"key":"437_CR30","doi-asserted-by":"crossref","first-page":"114306","DOI":"10.1016\/j.ejca.2024.114306","volume":"211","author":"M Menzel","year":"2024","unstructured":"Menzel M, Martis-Thiele M, Goldschmid H, Ott A, Romanovsky E, Siemanowski-Hrach J, Seillier L, Br\u00fcchle NO, Maurer A, Lehmann K-V et al (2024) Benchmarking whole exome sequencing in the German network for personalized medicine. Eur J Cancer 211:114306","journal-title":"Eur J Cancer"},{"key":"437_CR31","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1093\/nar\/gkad841","volume":"51","author":"S M\u00fcller-Dott","year":"2023","unstructured":"M\u00fcller-Dott S, Tsirvouli E, Vazquez M, Flores ROR, Badia-i-Mompel P, Fallegger R, T\u00fcrei D, L\u00e6greid A, Saez-Rodriguez J (2023) Expanding the coverage of regulons from high-confidence prior knowledge for accurate estimation of transcription factor activities. Nucleic Acids Res 51:10934\u201310949","journal-title":"Nucleic Acids Res"},{"key":"437_CR32","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","volume":"66","author":"KE O\u2019Reilly","year":"2006","unstructured":"O\u2019Reilly KE, Rojo F, She Q-B, Solit D, Mills GB, Smith D, Lane H, Hofmann F, Hicklin DJ, Ludwig DL et al (2006) mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 66:1500\u20131508","journal-title":"Cancer Res"},{"key":"437_CR33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s42003-021-02257-0","volume":"4","author":"K Santos-de-Frutos","year":"2021","unstructured":"Santos-de-Frutos K, Djouder N (2021) When dormancy fuels tumour relapse. Commun Biol 4:747","journal-title":"Commun Biol"},{"key":"437_CR34","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02391-6","volume":"9","author":"M Schubert","year":"2018","unstructured":"Schubert M, Klinger B, Kl\u00fcnemann M, Sieber A, Uhlitz F, Sauer S, Garnett MJ, Bl\u00fcthgen N, Saez-Rodriguez J (2018) Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat Commun 9:20","journal-title":"Nat Commun"},{"key":"437_CR35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-023-03650-2","volume":"485","author":"A Sk\u00e1lov\u00e1","year":"2024","unstructured":"Sk\u00e1lov\u00e1 A, Taheri T, Bradov\u00e1 M, Van\u011b\u010dek T, Franchi A, Slouka D, Kostliv\u00fd T, Rezende G, de, Mich\u00e1lek J, Klub\u00ed\u010dkov\u00e1 N et al (2024) SMARCB1-deficient sinonasal adenocarcinoma: a rare variant of SWI\/SNF-deficient malignancy often misclassified as high-grade non-intestinal-type sinonasal adenocarcinoma or myoepithelial carcinoma. Virchows Arch 485:245\u2013256","journal-title":"Virchows Arch"},{"key":"437_CR36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street K, Risso D, Fletcher RB, Das D, Ngai J, Yosef N, Purdom E, Dudoit S (2018) Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genom 19:477","journal-title":"BMC Genom"},{"key":"437_CR37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1158\/2767-9764.CRC-22-0260","volume":"4","author":"V Subbiah","year":"2023","unstructured":"Subbiah V, Coleman N, Piha-Paul SA, Tsimberidou AM, Janku F, Rodon J, Pant S, Dumbrava EE, Fu S, Hong DS et al (2023) Phase I study of mTORC1\/2 inhibitor sapanisertib in combination with metformin in patients with mTOR\/AKT\/PI3K pathway alterations and advanced solid malignancies. Cancer Res Commun 4:378\u2013387","journal-title":"Cancer Res Commun"},{"key":"437_CR38","first-page":"589","volume":"30","author":"Z Tao","year":"2025","unstructured":"Tao Z, Shao W, Zhou H, Xia S, Zeng J, Ren J, Wang X, Zhu H (2025) Role of signaling pathways in lung cancer development and advances in targeted therapies (Review). Oncol Lett 30:589","journal-title":"Oncol Lett"},{"key":"437_CR39","doi-asserted-by":"crossref","first-page":"gr.257246.119","DOI":"10.1101\/gr.257246.119","volume":"31","author":"S Uhrig","year":"2021","unstructured":"Uhrig S, Ellermann J, Walther T, Burkhardt P, Fr\u00f6hlich M, Hutter B, Toprak UH, Neumann O, Stenzinger A, Scholl C et al (2021) Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res 31:gr.257246.119","journal-title":"Genome Res"},{"key":"437_CR40","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1177\/030006051204000608","volume":"40","author":"Y Wang","year":"2012","unstructured":"Wang Y, Wang L, Li D, Wang H, Chen Q (2012) Mesothelin promotes invasion and metastasis in breast cancer cells. J Int Me\u0301d Res 40:2109\u20132116","journal-title":"J Int Me\u0301d Res"},{"key":"437_CR41","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yan J, Li L, Chen T, Guo J, Lei L, Wu S, Zhu L, Chen X, Liu B (2025) Mesothelin-directed protein-drug conjugates for mesothelin-low solid tumor therapy. Nat Commun 16:7889","journal-title":"Nat Commun"},{"key":"437_CR42","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2010.09.006","volume":"18","author":"BG Wilson","year":"2010","unstructured":"Wilson BG, Wang X, Shen X, McKenna ES, Lemieux ME, Cho Y-J, Koellhoffer EC, Pomeroy SL, Orkin SH, Roberts CWM (2010) Epigenetic antagonism between polycomb and SWI\/SNF complexes during oncogenic transformation. Cancer Cell 18:316\u2013328","journal-title":"Cancer Cell"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00437-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00437-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00437-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:32:39Z","timestamp":1781505159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00437-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,15]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00437-1","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CBW served as an advisor for Astra Zeneca, Daiichi Sankyo, BMS, Frankfurt Institute of Clinical Cancer Research (IKF), Incyte, Johnson & Johnson, Roche, Taiho, received honoraria from Amgen, Astra Zeneca, Bayer, BMS, Daiichi Sankyo, GSK, Johnson & Johnson, Lilly, MSD, Merck, Pierre Fabre, QuIP GmbH, Roche, Servier, received travel support from Astra Zeneca, Daiichi Sankyo, Bayer, Johnson & Johnson, Roche, Servier, Taiho, received research funding from Roche (institutional), serves as an officer for European Society of Medical Oncology (ESMO), Deutsche Krebshilfe (DKH) and Arbeitsgemeinschaft internistische Onkologie (AIO) and is a member of the EU Commission expert group: Mission Board for cancer and of the BMFTR steering committee: Strategiekreis Dekade gegen Krebs. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}